Donald Trump was harshly criticized for appearing indifferent to the fainting of a senior representative of the pharmaceutical company Novo Nordisk.
Mexico City, November 6 (However).- Gordon Findlayexecutive director of the pharmaceutical Novo Nordiskse fainting this Thursday afternoon at Oficina Oval of the White House during a press conference. However, what caught attention was the President’s reaction Donald Trump who acted surprised, but indifferent before the event.
In the video of the event, which circulates on social networks, you can see the moment in which Findlaywho was next to the American president’s desk, collapses while David RicksCEO of the pharmaceutical company Lillyhe spoke. “Gordon, are you okay?” Ricks asked, seeing Findlay fade away.
The photo is misleading. pic.twitter.com/9ZKIRrattF
— Africa Research Desk (@MightiJamie) November 6, 2025
At that moment, all the officials present in the room turned to assist the pharmaceutical representative under the gaze of Trump, who only got up from his seat, somewhat dismayed by the event, but remained motionless in front of the Findlay.
Reporters covering the event rushed to document the event and capture Trump in front of his desk waiting for the press conference to resume.
The media also reported that Robert Kennedy, Secretary of Health, rushed out of the office, in an unusual and somewhat incomprehensible reaction, although the US administration later clarified that he went to seek help for the fainted person.
BREAKING: RFK Jr. flees the scene after Novo Nordisk Executive Gordon Findlay collapsed in the Oval Office. pic.twitter.com/j5B3Q57Qk8
— Ed Krassenstein (@EdKrassen) November 6, 2025
White House spokesperson Karoline Leavitt intervened to report what happened. “During the announcement in the Oval Office, a representative of one of the companies fainted. The medical team acted quickly and the man is fine. The press conference will resume shortly,” he reported.
Senior executives from large pharmaceutical companies went to the White House this Thursday to announce the agreement by which the Trump administration will lower the price of Wegoby and other medications that have been extremely popular in recent years, due to their success in losing weight and that millions of Americans use.